Antibe Therapeutics Inc(Pre-Merger) ATBPF

COVID ... BioPUB ...

[MrMugsy]

Am I wrong in saying that those were some positive words about H2S and work being done at the national lab level?  Sounds like it's positive yet they can't really talk to it.

-----------

We know sulphur at the cell level can protect w.r.t. virus penetration.

So many tidbits thrown at us yet ... no one throwing us a bone.

hahaha !

[Doccole]

Finally saw BioPub.  Good direction.  H2s was surprising.  January/February sounds like a uplisting.   Going to add more, sell some when it doubles from here and ride out the balance until completion or major partnership.  I'm waiting for a billion in cash, and a market cap of 200m, lol.  Ready 21 

[Forestview]

Ha...I'm assuming you mean way more than a $200M market cap, Doc...?

[Doccole]

Yeah, I'm just being sarcastic. I am getting a little anxious and ready for it to bounce some! I get the impression the offer was made to the deal maker.  I'm healthcare, not sure how vital that is.....!? Some are saying significant, I have been minimizing it.  Also under the impression we will be announcing a regional deal sooner than later.  Just "my gut" (pun

[MrMugsy]

I see ATE getting back into negotiations after Christmas and that continues until they are done - whenever that may be. I see the comprehensive corporate update just before J.P.Morgan ... around January 10th. Going into J.P.Morgan, we start seeing some bigger buying activity, as the corporate update excites institutions. Then we are heavy into Phase 3 countdown, with End-of-Phase2 meeting and the

[Pragmatist]

I was intrigued by Stauffer's comments on the OTEN 1-month exposure trial in Toronto.  This was not in the original program, but seemed to come about because of the Covid pandemic.   The National Microbiology Laboratory is currently conducting more than 100 Covid-19 research studies.  Details are confidential.   I suspect that the company is participating in this